Management of Hair Fall through Rovaan Poshaka Taila
- Conditions
- Health Condition 1: L639- Alopecia areata, unspecified
- Registration Number
- CTRI/2020/01/022718
- Lead Sponsor
- Multani Pharmaceuticals Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Subjects having diffuse hair fall
Subjects willing to participate in the study
Subjects able to provide signed ICF prior to any study related procedure
1.Subjects below 18 years and above 45 years of age
2.Subjects on immunosuppressive drugs with evidence of skin infection
3.Subjects who had used any topical therapy for diffuse hair loss in the 2 weeks prior to the initiation of study
4.Individuals with immediate life threatening diseases such as pre-existing cardiovascular, liver or neoplastic diseases
5.Individuals who received any immunosuppressant, sedative, hypnotic or tranquilizer within 14 days prior to enrollment
6.Individuals with any psychiatric illness which may impair the ability to provide written ICF.
7.Individuals participating in any other clinical trial.
8.Pregnant and lactating females.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in Hair FallTimepoint: 45 days
- Secondary Outcome Measures
Name Time Method Improvement in quality of hairs and scalpTimepoint: 45 days